ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008

In Brief: Wieand Named Director, Biostatistical Center For NSABP; LeMaistre Honored By AMA

June 30, 1995

NCI Recruiting Senior Scientist To Lead AIDS research

May 17, 1996

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

September 15, 1995

NSABP Executive Committee Joins Fisher In Suit Against Pitt

August 5, 1994

In Brief: Online Genetics Glossary; ORI Misconduct Finding

February 5, 1999